Iovance Biotherapeutics’ real-world data reinforces the clinical value of Lifileucel (amtagvi) in advanced melanoma. The recently released data from...

Immix Biopharma announced promising safety data for its sterically-optimized CAR-T cell therapy, NXC-201, in patients with AL amyloidosis, notably...

Rakovina Therapeutics’ partner, Variational AI, has been awarded the 2025 Emerging Company of the Year – Biotech by Life...

Profusa, a commercial-stage digital health company, has officially begun trading on Nasdaq under the ticker “PFSA” following its business...

Pelthos Therapeutics has launched Zelsuvmi™ (berdazimer) topical gel, 10.3%, a first-in-class topical treatment for molluscum contagiosum (molluscum) in patients...

Biogen and Stoke Therapeutics have presented new data on zorevunersen, their investigational antisense oligonucleotide for Dravet syndrome, further solidifying...

Soleno Therapeutics projects between $31 million and $33 million in net revenue for Vykat XR (diazoxide choline) in the...

DXS International’s clinical decision support solution, ExpertCare, has demonstrated significant improvements in hypertension management and cost savings for the...

Telix Pharmaceuticals has secured a permanent Healthcare Common Procedure Coding System (HCPCS) Level II code (A9616) from the U.S....

Nurix Therapeutics, a clinical-stage biotech focused on targeted protein degradation, reported positive financial results for Q2 2025, driven by...